Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

A New Hope for Tuberculosis

The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its proprietary pharmacophores, MM4TB will continue to develop new drugs for TB treatment.

In the video, Prof. Stewart Cole, Coordinator of MM4TB and chair of the Global Health Institute at the EPFL, describes a new drug candidate and how it kills Tuberculosis bacteria.

Visit the institute http://ghi.epfl.ch/
Visit the lab http://cole-lab.epfl.ch/